Avanir Pharmaceuticals Inc. received the FDA's blessing to begin a Phase III trial of Neurodex in pain, at the same time continuing work on its rolling new drug application in pseudobulbar affect. (BioWorld Today)

Avanir Pharmaceuticals Inc. received the FDA's blessing to begin a Phase III trial of Neurodex in pain, at the same time continuing work on its rolling new drug application in pseudobulbar affect. (BioWorld Today)